Alerts will be sent to your verified email
Verify EmailPANJON
|
Panjon
|
Sandu Pharmaceutical
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.02 % | 3.72 % | 3.38 % |
|
5yr average Equity Multiplier
|
1.09 | 1.33 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.85 | 1.23 | 0.77 |
|
5yr Avg Net Profit Margin
|
-6.52 % | 2.27 % | -8.22 % |
|
Price to Book
|
2.18 | 0.88 | 0.67 |
|
P/E
|
49.08 | 23.9 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
77.42 Days | 48.49 Days | 11.27 Days |
|
Inventory Days
|
126.87 Days | 74.6 Days | 46.83 Days |
|
Days Receivable
|
30.38 Days | 26.14 Days | 10.61 Days |
|
Days Payable
|
36.87 Days | 72.73 Days | 83.41 Days |
|
5yr Average Interest Coverage Ratio
|
-9.32 | 28.2 | -18.91 |
|
5yr Avg ROCE
|
-4.48 % | 5.33 % | 1.03 % |
|
5yr Avg Operating Profit Margin
|
-8.95 % | 3.77 % | 9.99 % |
|
5 yr average Debt to Equity
|
0.09 | 0.0 | 0.2 |
|
5yr CAGR Net Profit
|
n/a | 0.39 % | n/a |
|
5yr Average Return on Assets
|
-4.21 % | 2.79 % | -5.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
56.69 % | 37.79 % | 53.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 20.66 % |
|
Change in Promoter Holding (3 Yrs)
|
4.66 % | -14.62 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Panjon
|
Sandu Pharmaceutical
|
Lasa Supergenerics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|